About 41% of US adults
have blood vitamin D below the level considered sufficient.
Peer-reviewed analysisGlucosamine HCl is the lead active here, studied most for cartilage and joint cushioning. Vitamin D3 is the most studied active here, with 20 human studies behind it, each one cited. Each serving carries 1,500 mg of Glucosamine HCl, inside the range the published research used. Who it fits: for everyone, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 6 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Strong evidence, strong dose".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 385 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
About 41% of US adults
have blood vitamin D below the level considered sufficient.
Peer-reviewed analysis36.5% of US adults
aged 18 and over had pain in a hip, knee, or foot in the past 3 months, in the 2019 National Health Interview Survey.
CDC National Center for Health Statistics, 202030.7% of US adults
aged 18 and over had pain in a shoulder, elbow, wrist, or hand in the past 3 months, in the 2019 National Health Interview Survey.
CDC National Center for Health Statistics, 202057.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics30.2% of non-Hispanic white women
aged 18 and over reported pain, aching, or stiffness in or around a joint lasting more than 3 months, in the 2013 to 2014 National Health Interview Survey.
CDC National Center for Health Statistics, 201628.4% of non-Hispanic white men
aged 18 and over reported pain, aching, or stiffness in or around a joint lasting more than 3 months, in the 2013 to 2014 National Health Interview Survey.
CDC National Center for Health Statistics, 201695% of US adults
aged 19 and over had vitamin D intake from food and beverages below the Estimated Average Requirement, in National Health and Nutrition Examination Survey data from 2005 to 2016.
National Health and Nutrition Examination Survey analysis, 202018.8% of US adults aged 75 and over
needed the help of another person to carry out routine daily tasks outside the home, and 10.6% needed help with basic daily tasks like bathing or dressing, in the 2014 National Health Interview Survey.
CDC National Center for Health Statistics, 201659 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Randomised trial, 2025
A boswellia extract lowered muscle soreness scores versus placebo by about 8 mm after downhill running in men, over 10 days.
Frontiers in Sports and Active LivingRandomised trial, 2019
In a 120 day pilot trial of 48 adults, a standardized boswellia serrata extract was linked to less knee discomfort and stiffness and a lower inflammation marker compared with placebo.
Phytotherapy ResearchRandomised trial, 2023
In 88 healthy adults with mild knee discomfort, 2 g a day for 12 weeks improved knee quality-of-life scores against placebo.
NutrientsRandomised trial, 2019
In 60 adults with knee pain and extra weight, 600 mg of plant-based chondroitin daily for 12 weeks improved knee function by 10.6 points and symptom scores by 12.2 points.
NutrientsCohort study, 2025
In a propensity-score-matched cohort, regular glucosamine use was associated with lower incidence of several age-related chronic conditions. An association in observational data, not a demonstrated cause.
Aging Clinical and Experimental ResearchMeta-analysis, 2024
Across 10 trials in 318 athletes, vitamin D3 raised blood vitamin D by about 14.8 nmol/L and hinted at better muscle strength, though few trials leave that uncertain.
Frontiers in NutritionSystematic review, 2025
Across human trials, glucosamine and chondroitin were well tolerated, with modest improvements in knee joint comfort and function in some studies and no difference detected from placebo in others.
NutrientsSystematic review and meta-analysis, 2024
Pooling 13 chondroitin sulfate trials, it found lower reported joint pain intensity and improved everyday physical function compared with placebo.
InflammopharmacologyMeta-analysis, 2014
Pooling 30 trials of 5,615 adults, vitamin D gave a small rise in overall muscle strength, with no measurable effect on muscle mass or power.
Journal of Clinical Endocrinology and MetabolismRandomised trial, 2025
Vitamin D3 supplementation changed the inflammatory protein CHI3L1 and oxidative stress markers in adults with a chronic demyelinating condition. These are markers, not clinical outcomes.
Neuropsychopharmacology ReportsRandomised trial, 2025
A cartilage-supporting nutritional supplement changed reported knee symptom scores and quality of life measures against comparator over the study period.
Scientific ReportsOpen-label trial, 2024
A combination of hydrolysed type II collagen, methylsulfonylmethane, glucosamine sulfate and chondroitin sulfate changed reported symptom and function scores over the study period. The design cannot separate the four components.
Turkish Journal of Physical Medicine and RehabilitationSystematic review and meta-analysis, 2020
Pooling seven randomised trials in 545 people, Boswellia was associated with less knee joint discomfort on the WOMAC scale (about 14 points) and better joint function and stiffness compared with placebo.
BMC Complementary Medicine and TherapiesMeta-analysis, 2024
Across 13 randomised trials in adults with knee joint pain and stiffness, pooled results did not detect an overall difference in joint scores versus control (p = 0.09 for WOMAC), though the placebo-controlled subgroup showed lower WOMAC scores with boswellia extract.
Phytotherapy ResearchSystematic review and meta-analysis, 2015
Across 43 trials and about 4,900 people, chondroitin improved joint comfort by roughly 8 points on a 0 to 100 pain scale versus placebo in shorter studies, a small to moderate difference.
Cochrane Database of Systematic ReviewsSystematic review, 2025
Reviewing the evidence in adults with worn knee joints, slow-acting joint agents such as chondroitin were associated with small gains in comfort and function that build over months rather than days.
Aging clinical and experimental researchRandomised trial, 2025
In a small trial of healthy runners taking 1 g a day for 30 days before a half marathon, 29 immune-response mRNAs shifted in the hours after the run, at a lower dose than earlier work used.
NutrientsRandomised trial, 2025
A standardised Boswellia serrata plus Terminalia chebula extract combination was assessed in adults, and the reported effects belong to the fixed combination rather than to boswellia alone.
Frontiers in NutritionRandomised trial, 2025
A double-blind trial compared a multi-nutrient supplement plus exercise against exercise alone in older adults with age-related knee joint wear. Glucosamine was one component of the blend, so its individual contribution cannot be separated.
Age and AgeingSystematic review and network meta-analysis, 2018
Across trials of 12 months or longer, glucosamine sulfate was linked to a small reduction in knee pain versus placebo, and it was the only form whose pain benefit held after excluding higher-bias trials.
JAMAMeta-analysis, 2024
Across 20 studies, daily vitamin D3 raised blood vitamin D levels by about 10.4 nmol/L more than the same dose of vitamin D2, roughly 40 percent more.
Advances in NutritionRandomised trial, 2015
In a crossover trial, glucosamine and chondroitin changed inflammation and oxidative stress markers compared with placebo, not joint symptoms directly.
PLoS OneMeta-analysis, 2012
In trials directly comparing the two forms, vitamin D3 raised blood 25-hydroxyvitamin D more than vitamin D2 did (P = 0.001).
American Journal of Clinical NutritionRandomised trial, 2025
This pilot crossover compared plasma pharmacokinetics of two glucosamine presentations and reported the measured exposure profile for each. A pharmacokinetic marker, not a clinical outcome, and the sample was a pilot.
NutrientsMeta-analysis, 2014
Across 23 trials of 4,082 adults, vitamin D raised bone mineral density at the femoral neck by about 0.8%, with no measurable change at the spine, hip, or other sites.
LancetRandomised trial, 2022
In 24 adults with knee joint pain, adding glucosamine and chondroitin sulfate to four weeks of manual therapy and resistance training produced no detectable extra gain in pain, function, range of motion or strength over the therapy alone.
Journal of the Pakistan Medical AssociationCohort study, 2023
An association was reported between habitual glucosamine use and major cardiovascular events in cohort data, with the authors noting this could reflect healthy-user behavior rather than a true effect.
Mayo Clinic ProceedingsMeta-analysis, 2024
Boswellia lowered a blood sugar marker plus cholesterol and triglycerides in adults with high blood sugar, with no change in fasting glucose or HDL.
The paperCohort study, 2024
No association was detected between glucosamine supplementation and later neurological diagnoses in this prospective cohort. A failure to detect a relationship, which is not evidence that none exists.
Journals of Gerontology Series ARandomised trial, 2015
In athletes recovering from knee ligament reconstruction, the authors reported their measured cartilage turnover and functional endpoints between glucosamine and placebo arms. A single small trial in a narrow population.
Research in Sports MedicinePopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
In the trial record, blood vitamin D rises for about 3 months of daily vitamin D3 and then holds at a plateau, near 69 nmol/L at 1,000 IU a day, from a starting level near 41 nmol/L.
After a single 1500 mg oral dose of glucosamine sulfate in a randomized crossover study of 10 healthy adults, glucosamine was followed in blood over 24 hours, and its metabolite glucosamine-6-sulfate peaked at 6 to 8 hours with a longer half-life.
In an open-label, single-arm trial of 29 healthy adults taking 1500 mg glucosamine hydrochloride daily, stool characteristics changed within the 2 weeks of intake.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
Six ingredients, from each one's own page.
25-hydroxyvitamin D climbs over roughly six to twelve weeks of daily dosing before it plateaus. It's a blood level you watch rather than a feeling.
The change is gradual and shows up as less stiffness in the first hour of the day rather than as a sensation you can time.
Give it a few weeks. Joint comfort and mobility studies mostly read out between weeks four and eight, and that is where daily users tend to notice the change.
Give it eight to twelve weeks of daily use. The trials that report anything measure at around three months, so the change arrives slowly and steadily.
Joint comfort studies read out at eight to twelve weeks, and that is the honest window. Nothing here works on the day you take it.
Joint comfort work runs over weeks rather than days, so plan on about a month of daily use. Any digestive effects turn up far sooner.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
What each form is, and where it fits in a formula. Measured findings carry the study that reported them.
The animal-sourced form of vitamin D, made in skin under UVB light and produced commercially from lanolin. Fat-soluble, so it travels with dietary fat and is stored in body fat.
In a 12-week double-blind randomised controlled trial in 108 young women in urban Bangalore, most of whom began vitamin D-deficient, daily vitamin D3 at 400, 600 or 800 IU in a fortified wafer raised serum 25-hydroxyvitamin D, parathyroid hormone fell over time, and effects on bone-turnover markers were modest and not dose specific. The 800 IU dose brought 65 percent of participants to sufficiency.
Glucosamine bound to hydrochloric acid as its counterion, with no added mineral salt. Because the chloride counterion is light, this form carries a higher proportion of glucosamine by weight than the sulfate-plus-chloride salts.
The sodium salt of chondroitin sulfate, a sulfated glycosaminoglycan built from repeating disaccharide units of N-acetylgalactosamine and glucuronic acid carrying sulfate groups. Extracted from bovine or porcine cartilage such as trachea, it is predominantly sulfated at the 4-position (chondroitin-4-sulfate, the CS-A type).
Descriptions of the form itself, read from the cited studies. Not a comparison between products and not a statement about any individual.
It is a tablet, so the amount per serving is fixed and it stores well.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.